Sarah H. O’Brien

7.9k total citations · 2 hit papers
191 papers, 3.9k citations indexed

About

Sarah H. O’Brien is a scholar working on Hematology, Internal Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sarah H. O’Brien has authored 191 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Hematology, 44 papers in Internal Medicine and 43 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sarah H. O’Brien's work include Venous Thromboembolism Diagnosis and Management (44 papers), Platelet Disorders and Treatments (40 papers) and Blood Coagulation and Thrombosis Mechanisms (37 papers). Sarah H. O’Brien is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (44 papers), Platelet Disorders and Treatments (40 papers) and Blood Coagulation and Thrombosis Mechanisms (37 papers). Sarah H. O’Brien collaborates with scholars based in United States, Canada and United Kingdom. Sarah H. O’Brien's co-authors include Joseph Stanek, Richard Holubkov, Evelyn Cohen Reis, Jennifer Klima, Bryce A. Kerlin, Sean D. Candrilli, Bhuvana A. Setty, Jan Cools, Rajesh Balkrishnan and Donald L. Yee and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Sarah H. O’Brien

185 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease

2021 181 citations Veronica H. Flood, Sarah H. O’Brien et al. Blood Advances profile →
The relationship between heavy menstrual bleeding, iron deficiency, and iron deficiency anemia

2023 58 citations Sarah H. O’Brien et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah H. O’Brien United States	34	1.9k	969	723	614	539	191	3.9k
Kate M. Fleming United Kingdom	34	440 0.2×	386 0.4×	397 0.5×	367 0.6×	313 0.6×	92	4.2k
Catherine Nelson‐Piercy United Kingdom	47	1.6k 0.8×	1.1k 1.1×	348 0.5×	2.8k 4.6×	1.5k 2.8×	247	7.9k
Eleftherios C. Vamvakas United States	42	1.5k 0.8×	170 0.2×	521 0.7×	395 0.6×	256 0.5×	113	6.2k
Kitty W.M. Bloemenkamp Netherlands	44	920 0.5×	477 0.5×	137 0.2×	1.8k 2.9×	566 1.1×	229	5.7k
Pelle G. Lindqvist Sweden	38	1.0k 0.5×	647 0.7×	122 0.2×	848 1.4×	1.0k 1.9×	159	5.0k
Laila J. Tata United Kingdom	39	480 0.2×	448 0.5×	54 0.1×	1.2k 2.0×	453 0.8×	130	4.5k
Flemming Hald Steffensen Denmark	34	363 0.2×	654 0.7×	45 0.1×	486 0.8×	1.5k 2.7×	107	3.7k
Sandra Zelman Lewis United States	15	1.1k 0.6×	295 0.3×	286 0.4×	293 0.5×	402 0.7×	28	3.4k
Finn Egil Skjeldestad Norway	31	606 0.3×	551 0.6×	47 0.1×	1.4k 2.2×	377 0.7×	184	4.2k
Michelle Hladunewich Canada	42	258 0.1×	110 0.1×	263 0.4×	1.4k 2.2×	456 0.8×	153	5.1k

Countries citing papers authored by Sarah H. O’Brien

Since Specialization

Citations

This map shows the geographic impact of Sarah H. O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah H. O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah H. O’Brien more than expected).

Fields of papers citing papers by Sarah H. O’Brien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah H. O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah H. O’Brien. The network helps show where Sarah H. O’Brien may publish in the future.

Co-authorship network of co-authors of Sarah H. O’Brien

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah H. O’Brien. A scholar is included among the top collaborators of Sarah H. O’Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah H. O’Brien. Sarah H. O’Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

O’Brien, Sarah H., Joseph Stanek, Andrew A. House, et al.. (2024). Trends in Pregnancy Outcomes in People with Sickle Cell Disease and Medicaid Insurance (2006–2018). Journal of Women s Health. 34(1). 21–26. 2 indexed citations

Stanek, Joseph, et al.. (2023). Assessment of ISTH-BAT Scores in a Primary Care Clinic Population of Menstruating Adolescents. Blood. 142(Supplement 1). 1243–1243. 1 indexed citations

Agarwal, Shreya, Joseph Stanek, Sara K. Vesely, et al.. (2023). Pregnancy‐related thromboembolism in women with sickle cell disease: An analysis of National Medicaid Data. American Journal of Hematology. 98(11). 1677–1684. 11 indexed citations

Dietrich, Kevin, Zhenning Wang, Sarah H. O’Brien, et al.. (2023). OC 38.2 Acquired Abnormalities in the Hemostatic System during Induction Chemotherapy in Treatment of Childhood Acute Lymphoblastic Leukemia (ALL): A Biomarker Sub-Study of the PREVAPIX-ALL Trial. Research and Practice in Thrombosis and Haemostasis. 7. 100522–100522. 1 indexed citations

Davila, Jennifer, William B. Mitchell, Kerry Morrone, et al.. (2023). Venous thromboembolism prophylaxis practices for patients with sickle cell disease prior to and during the COVID-19 pandemic. Blood Coagulation & Fibrinolysis. 34(8). 471–477. 1 indexed citations

Abrams, Mary Ann, Joseph Stanek, Sarah H. O’Brien, et al.. (2022). Acceptability to and Engagement With a Virtual Sickle Cell Trait Education Program (SCTaware): Single-Center Prospective Study. JMIR Formative Research. 6(11). e38780–e38780. 2 indexed citations

O’Brien, Sarah H., Sherif M. Badawy, Seth J. Rotz, et al.. (2022). The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question. Blood Advances. 6(2). 679–685. 6 indexed citations

Creary, Susan E., Joseph Stanek, Kathryn King, et al.. (2022). Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia. Pediatric Blood & Cancer. 69(6). e29607–e29607. 8 indexed citations

Zia, Ayesha, et al.. (2021). Iron deficiency and fatigue among adolescents with bleeding disorders. American Journal of Hematology. 97(1). 60–67. 20 indexed citations

10.

Abrams, Mary Ann, et al.. (2021). Closing Knowledge Gaps Among Parents of Children with Sickle Cell Trait. Blood. 138(Supplement 1). 2980–2980. 1 indexed citations

11.

Abe, Karon, et al.. (2019). Higher rates of bleeding and use of treatment products among young boys compared to girls with von Willebrand disease. American Journal of Hematology. 95(1). 10–17. 15 indexed citations

12.

Stanek, Joseph, et al.. (2019). Anti-Factor Xa–Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort. The Journal of Pediatrics. 209. 212–219.e1. 8 indexed citations

13.

Nahata, Leena, Nicole M. Caltabellotta, Nicholas D. Yeager, et al.. (2019). Congruence of Reproductive Goals and Fertility-Related Attitudes of Adolescent and Young Adult Males and Their Parents After Cancer Treatment. Journal of Adolescent and Young Adult Oncology. 8(3). 335–341. 13 indexed citations

14.

Gerhardt, Cynthia A., Nicholas D. Yeager, Joseph R. Rausch, et al.. (2018). Interest in Learning About Fertility Status Among Male Adolescent and Young Adult Survivors of Childhood Cancer. Journal of Adolescent and Young Adult Oncology. 8(1). 61–66. 6 indexed citations

15.

Hanson, Sheila J., E. Vincent S. Faustino, Arash Mahajerin, et al.. (2016). Recommendations for venous thromboembolism prophylaxis in pediatric trauma patients. The Journal of Trauma: Injury, Infection, and Critical Care. 80(5). 695–701. 20 indexed citations

16.

Mahajerin, Arash, John K. Petty, Sheila J. Hanson, et al.. (2016). Prophylaxis against venous thromboembolism in pediatric trauma. The Journal of Trauma: Injury, Infection, and Critical Care. 82(3). 627–636. 35 indexed citations

17.

Klima, Jennifer, et al.. (2011). Young adults with SCD in US children's hospitals: Are they different from adolescents?. Pediatric Blood & Cancer. 58(5). 741–745. 14 indexed citations

18.

O’Brien, Sarah H.. (2008). Decision Analysis in Pediatric Hematology. Pediatric Clinics of North America. 55(2). 287–304. 8 indexed citations

19.

Wang, Wei, et al.. (2008). Applying diagnostic criteria for type 1 von Willebrand disease to a pediatric population. Pediatric Blood & Cancer. 52(1). 102–107. 7 indexed citations

20.

O’Brien, Sarah H., Kathy Haley, Kelly J. Kelleher, et al.. (2008). Variation in DVT Prophylaxis for Adolescent Trauma Patients. Journal of Trauma Nursing. 15(2). 53–57. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact